DECREASED SIALIDASE ACTIVITY IN MONONUCLEAR LEUKOCYTES OF TYPE-1 DIABETIC SUBJECTS - RELATIONSHIP TO DIABETIC COMPLICATIONS AND GLYCEMIC CONTROL

被引:5
作者
WATERS, PJ
FLYNN, MD
PENNOCK, CA
CORRALL, RJM
GREENWOOD, RJ
EISENTHAL, R
机构
[1] PRINCE PHILIP DENT HOSP,LLANELLI SA14 8QF,DYFED,WALES
[2] UNIV BATH,DEPT BIOCHEM,BATH BA2 7AY,AVON,ENGLAND
关键词
SIALIDASE (= NEURAMINIDASE); SIALIC ACID; LYSOSOMES; GLYCOSIDE HYDROLASES; TYPE; 1; DIABETES; DIABETIC ANGIOPATHIES;
D O I
10.1111/j.1464-5491.1995.tb00567.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Leucocyte surface sialic acid content influences surface charge, deformability, and leucocyte-endothelial interaction. Abnormal leucocyte structure and function contributes both to microvascular damage and diabetic complications. The aim of this study was to investigate altered leucocyte SA metabolism in diabetic subjects and measure lysosomal sialidase which regulates leucocyte surface sialylation. We examined 26 Type 1 (insulin-dependent) diabetic subjects with retinopathy, 26 Type 1 diabetic subjects without complications, and 38 matched normal control subjects. Sialidase was assayed in freshly prepared sonicates of pure mononuclear leucocytes (MNLs), using the fluorometric substrate 4-methyl-umbelliferyl-N-acetylneuraminic acid. In the subjects with diabetes there was a significant negative correlation between MNL sialidase activity and both HbA(1c) (r(s) = 0.37, p = 0.007) and fructosamine (r(s) = -0.31, p 0.026). MNL sialidase activity was significantly decreased in diabetic subjects with clinical evidence of complications compared to control subjects. HbA(1c) was significantly higher (p = 0.036) in diabetic patients with complications compared to those without. The observed decrease in MNL sialidase activity related to diabetic control may be important in the pathogenesis of vascular damage. Diabetes-associated changes in sialylation of functional cell surface glycoconjugates may have important clinical consequences.
引用
收藏
页码:670 / 673
页数:4
相关论文
共 30 条
[1]  
Varki A., Selectins and other mammalian sialic acid‐binding lectins (Review), Curr Opin Cell Biol, 4, pp. 257-266, (1992)
[2]  
Rogers ME, Williams DT, Niththyananthan R., Rampling MW, Heslop KE, Johnston DG., Decrease in erythrocyte glycophorin sialic acid content is associated with increased erythrocyte aggregation in human diabetes, Clin Sci, 82, pp. 309-313, (1992)
[3]  
Cohen-Forterre L., Andre J., Mozere G., Peyroux J., Sternberg M., Kidney sialidase and sialyltransferase activities in spontaneously and experimentally diabetic rats, Biomed Pharmacol, 40, pp. 507-513, (1990)
[4]  
Pilatte Y., Bignon J., Lambre CR., Sialic acids as important molecules in the regulation of the immune system: pathophysiological implications of sialidases in immunity (Review), Glycobiology, 3, pp. 201-217, (1993)
[5]  
Landolfi NF, Leone J., Womack JE, Cook RG., Activation of T lymphocytes results in an increase in H2‐encoded neuraminidase, Immunogenetics, 22, pp. 159-167, (1985)
[6]  
Cross AS, Wright DG., Mobilization of sialidase from intracellular stores to the surface of human neutrophils and its role in stimulated adhesion responses of these cells, J Clin Invest, 88, pp. 2067-2076, (1991)
[7]  
Vanhaeverbeek M., Brohee D., Piro P., Lefevre A., Kennes B., Neve P., Mononuclear cells surface charge properties in diabetes and their relationship with glycation, Diabetologia, 34, (1991)
[8]  
Ernst E., Matrai A., Altered red and white blood cell rheology in type II diabetes, Diabetes, 35, pp. 1412-1415, (1986)
[9]  
Vermes I., Steinmetz ET, Zeyen LJJM, Van der Venn EA., Rheological properties of white blood cells are changed in diabetic patients with microvascular complications, Diabetologia, 30, pp. 434-436, (1987)
[10]  
Belch JJF., The white blood cell as a risk factor for thrombotic vascular disease, Vascular Medicine, 1, pp. 203-213, (1990)